Xbrane Sets Cash Target Ahead Of Lucentis Ambitions In 2022

Swedish Firm Names New Strategic Targets

 
• By Dean Rudge
  
Female eye with long eyelashes close up. Closeup shot of female gray - blue colour eye with day makeup. Beauty female eye with curl long eyelashes
Xbrane aims to launch ranibizumab in 2022 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products